최고의 종양 분자유전검사 (유전자검사)시행
분자유전검사실은 1991년, 세계적으로 초창기에, 창설되어 현재 60여종의 종양 유전자검사를 포함하여 약물유전자, 단일유전자질환, 감염질환 등에서 300여종의 검사를 시행하고 있습니다. 이러한 검사를 통해 최신의 종양진단과 치료법의 결정, 치료 후 경과관찰 등이 가능합니다.
|
분류 |
검사명 (종양,유전자,검사법) |
|
고형종양 |
Li-Fraumeni syndrome, TP53 sequencing |
|
Neurofibromatosis 1, NF1, sequencing, del/dup |
|
|
Neurofibromatosis 2, NF2 Sequencing |
|
|
VHL syndrome, VHL, sequencing, del/dup |
|
|
BRCA1 sequencing |
|
|
BRCA2 sequencing |
|
|
Tuberous Sclerosis, TSC1/TSC2 Sequencing, Del/dup |
|
|
Familial adenomatous polyposis, APC sequencing |
|
|
Hereditary Non-Polyposis Colon Cancer (HNPCC), MLH1/MSH2 gene, sequencing |
|
|
Peutz-Jeghers syndrome, STK11 sequencing |
|
|
Retinoblastoma, RB1, sequencing |
|
|
Hereditary multiple osteochondromas, EXT1 sequencing |
|
|
Hereditary multiple osteochondromas, EXT2 sequencing |
|
|
EGFR sequencing |
|
|
BRAF:sequencing |
|
|
Microsatellite instability: test |
|
|
PTEN sequencing |
|
|
CDH sequencing |
|
|
SMAD4 sequencing |
|
|
MDR sequencing |
|
|
혈액종양 |
Major bcr/abl, PCR |
|
Minor bcr/abl, PCR |
|
|
PML/RARA PCR |
|
|
E2A/PBX1 PCR |
|
|
AML1/ETO PCR |
|
|
Tel/AML1, PCR |
|
|
FLT3, ITD (internal tandem duplication) |
|
|
FLT3, TKD (terminal kinase domain) mutation |
|
|
NPM1 mutation |
|
|
JAK2, V617F |
|
|
Hemavision |
|
|
JAK2 exon 12, sequencing |
|
|
c-KIT |
|
|
FIP1L1/PDGFRA rearrangement |
|
|
NRAS |
|
|
KRAS |
|
|
BCR/ABL1, Imatinib resistance mutation |
|
|
BAALC, mRNA 정량 |
|
|
CBFB/MYH11 rearrangement, 정량 |
|
|
NPM1, mutation 정량 |
|
|
WT1, mRNA 정량 |
|
|
TEL/AML1 rearrangement, 정량 |
|
|
AML1/ETO rearrangement, 정량 |
|
|
PML/RARa rearrangement, 정량 |
|
|
IgH rearrangement |
|
|
TCR, gamma, rearrangement |
|
|
TCR, beta, rearrangement |
|
|
개인식별검사, pre-BMT test(STR) |
|
|
BMT monitoring, post-BMT test (STR) |